Inspiremd to report third quarter 2023 financial results and provide corporate business update on monday, november 6th

-conference call and webcast to be held at 8:30 a.m. est- tel aviv, israel and miami, oct. 30, 2023 (globe newswire) -- inspiremd, inc. (nasdaq: nspr), developer of the cguard™ embolic prevention stent system (eps) device for the treatment of carotid artery disease and stroke prevention, announced today it will report third quarter 2023 financial results on monday, november 6th, 2023, before the financial markets open.
NSPR Ratings Summary
NSPR Quant Ranking